74 related articles for article (PubMed ID: 19255303)
1. How many patients and how many complications does it take to decide if a drug is safe to use before surgery?
Kemeny MM
J Clin Oncol; 2009 Apr; 27(11):1917-8; author reply 1918. PubMed ID: 19255303
[No Abstract] [Full Text] [Related]
2. Bevacizumab and postoperative complications after hepatic surgery for colorectal metastases.
Petrelli NJ
J Clin Oncol; 2009 Apr; 27(11):1917; author reply 1918. PubMed ID: 19255304
[No Abstract] [Full Text] [Related]
3. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
D'Angelica M; Kornprat P; Gonen M; Chung KY; Jarnagin WR; DeMatteo RP; Fong Y; Kemeny N; Blumgart LH; Saltz LB
Ann Surg Oncol; 2007 Feb; 14(2):759-65. PubMed ID: 17103075
[TBL] [Abstract][Full Text] [Related]
4. Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
Bilchik AJ; Hecht JR
J Clin Oncol; 2008 Apr; 26(11):1786-8. PubMed ID: 18398144
[No Abstract] [Full Text] [Related]
5. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW
J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565
[TBL] [Abstract][Full Text] [Related]
6. In search of the black sheep: is it bevacizumab or extended chemotherapy?
Vauthey JN; Zorzi D
Ann Surg Oncol; 2009 Jun; 16(6):1463-4. PubMed ID: 19357926
[No Abstract] [Full Text] [Related]
7. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T
Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.
Brouquet A; Nordlinger B
J Surg Oncol; 2010 Dec; 102(8):932-6. PubMed ID: 21165995
[TBL] [Abstract][Full Text] [Related]
9. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.
Scappaticci FA; Fehrenbacher L; Cartwright T; Hainsworth JD; Heim W; Berlin J; Kabbinavar F; Novotny W; Sarkar S; Hurwitz H
J Surg Oncol; 2005 Sep; 91(3):173-80. PubMed ID: 16118771
[TBL] [Abstract][Full Text] [Related]
10. Histological and immediate postoperative outcome after preoperative cetuximab: case-matched control study.
Spiliotis J; Zoras O
World J Surg; 2011 May; 35(5):1153-4. PubMed ID: 21184075
[No Abstract] [Full Text] [Related]
11. Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.
Thornton AD; Ravn P; Winslet M; Chester K
Br J Surg; 2006 Dec; 93(12):1456-63. PubMed ID: 17115389
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear.
Windsor AC; Cohen R; Jiao LR; Stebbing J
Future Oncol; 2008 Dec; 4(6):741-4. PubMed ID: 19086837
[No Abstract] [Full Text] [Related]
13. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
[TBL] [Abstract][Full Text] [Related]
14. Evolution of neoadjuvant therapy for extended hepatic metastases--have we reached our (non-resectable) limit?
Adam R; Hoti E; Bredt LC
J Surg Oncol; 2010 Dec; 102(8):922-31. PubMed ID: 21165994
[TBL] [Abstract][Full Text] [Related]
15. Treatment of liver-limited metastatic colorectal cancer.
Hubbard JM; Alberts SR
Cancer J; 2010; 16(3):235-40. PubMed ID: 20526102
[TBL] [Abstract][Full Text] [Related]
16. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
Graziano F; Cascinu S
J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535
[No Abstract] [Full Text] [Related]
17. Curing patients with liver metastases from colorectal cancer.
Drug Ther Bull; 2011 Apr; 49(4):42-5; quiz i-ii. PubMed ID: 21467575
[TBL] [Abstract][Full Text] [Related]
18. Immediate post-operative hypersensitivity reaction to Cetuximab in patients preoperatively treated by the monoclonal antibody: what's wrong?
Delaunoit T
Acta Gastroenterol Belg; 2011 Sep; 74(3):475-6. PubMed ID: 22103058
[No Abstract] [Full Text] [Related]
19. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.
Ellis LM; Curley SA; Grothey A
J Clin Oncol; 2005 Aug; 23(22):4853-5. PubMed ID: 16051943
[No Abstract] [Full Text] [Related]
20. [The safety of perioperative bevacizumab use].
Mariani P
J Chir (Paris); 2010 Jan; 147 Suppl 1():S12-7. PubMed ID: 20172200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
